COVID-19 | Specialty

The covid-19 condition center is a comprehensive resource for clinical news and expert insights on covid-19. Read more at OncLive.

Dr. Wainberg on the Need for Continued Enrollment to Clinical Trials in CRC

September 20th 2021

Zev A. Wainberg, MD, discusses the importance of enrolling patients with colorectal cancer to clinical trials, despite the difficulties caused by COVID-19.

COVID-19 Continues to Result in High Admission, Fatality Rates Among Patients With CLL

September 18th 2021

COVID-19 continued to result in high admission and fatality rates among patients with chronic lymphocytic leukemia during the first 13 months of the pandemic, and although risk of severe infection was determined to be independent of age, CLL status, and treatment, being age 75 years or older was revealed to be a significant risk factor for death.

Black Men 97% Less Likely Than White Men to Receive Prostatectomy During COVID-19 Pandemic

August 31st 2021

During the height of the COVID-19 pandemic, Black patients were significantly less likely to undergo prostate cancer surgery compared with White patients, highlighting potential systemic inequities in care across medical specialties, and providing further rationale to recognize and the unintended diversion in cancer care due to the pandemic.

Florida Cancer Specialists & Research Institute Survey Finds Cancer Patients Support COVID-19 Vaccine & Mask Mandate

August 25th 2021

A survey of more than 6,800 cancer patients conducted this month by Florida Cancer Specialists & Research Institute found that patients overwhelmingly prefer that the FCS physicians, nurses and staff members who provide their care are vaccinated and wear masks to reduce the spread of COVID-19 and provide a safe environment within clinics.

NCCN Calls for Mandatory COVID-19 Vaccination for Healthcare Workers

August 23rd 2021

The National Comprehensive Cancer Center Network has issued an official statement calling on all healthcare systems to ensure that their workforces are immunized with one of the authorized COVID-19 vaccines.

FDA Approves First COVID-19 Vaccine

August 23rd 2021

The FDA has approved the Pfizer-BioNTech COVID-19 vaccine for use in the prevention of COVID-19 disease in individuals aged 16 years or older.

Cancer Screenings Recover From Height of COVID-19 Pandemic, But Disparities Remain

August 19th 2021

Chris Labaki, MD, and Quoc-Dien Trinh, MD, discuss their research on the decline in cancer screenings during the height of the COVID-19 pandemic, the recovery of these tests, and potential existing disparities to be addressed.

DFCI Faculty Relay Insight Into Confirmed Rebounds of Cancer Screenings After COVID-19

August 19th 2021

Dr. Labaki and Dr. Trinh discuss their research on the recovery of cancer screening tests, its link with potential racial disparities from the COVID-19 pandemic, and how the community can continue to emphasize the importance of cancer screening while working to close these disparities in cancer care.

Study Calls for COVID-19 Vaccination in Patients With Cancer to Enable Optimal Treatment Delivery During Pandemic

August 16th 2021

COVID-19 vaccination has been shown to induce high rates of seroconversion in patients with cancer, although those with hematologic malignancies have demonstrated lower immunogenicity and those who previously received immunosuppressive therapies appear to be less responsive.

Misinformation on Cancer Prevention Stems from COVID-19 Communication Efforts

August 15th 2021

One year ago, few objective observers would have suggested that the percentage of individuals who are currently fully vaccinated is less than 30%, despite the well-documented real-world success data for the vaccines in preventing serious illness, hospitalizations, and death from COVID-19 infection.

Cancer Screening Tests Rebound Following First Peak of COVID-19 Pandemic

August 10th 2021

After a dramatic decrease during the first peak of the COVID-19 pandemic, a substantial increase in cancer screening procedures during more recent time periods has been reported, according to data from a research letter published in Cancer Cell.

Dr. Labaki on Disparities in Mammography Screenings During the COVID-19 Pandemic

August 9th 2021

Chris Labaki, MD, discusses racial disparities with regard to mammography screenings during the COVID-19 pandemic.

Dr. Trinh on the Recovery of Cancer Screening Tests Following First COVID-19 Pandemic Peak

August 9th 2021

Quoc-Dien Trinh, MD, discusses findings from a study examining the temporal changes in cancer tests and diagnoses in a large healthcare system in the United States during the COVID-19 pandemic. 

ACCC Report: Immunotherapy Research Grew in 2020 Despite COVID-19 Pandemic

August 7th 2021

The COVID-19 pandemic had a relatively limited effect on immuno-oncology research, according to results from the Association of Community Cancer Centers fourth annual analysis of the IO landscape.

Rariy Reviews In-Home Infusion Initiative in Oncology

August 2nd 2021

Chevon M. Rariy, MD, discusses how the implementation of telehealth during the COVID-19 pandemic shed light on the need for increased access to care for patients with cancer, as well as the potential benefits in-home infusions could offer to patients receiving chemotherapy.

Cancer Organizations Call for Mandated COVID-19 Vaccines for Health Care Workers

July 26th 2021

More than 50 health care professional organizations, including the American Society of Hematology, the American Society of Clinical Oncology, the American Society for Radiation Oncology, the Society for Gynecologic Oncology, and the American Medical Association issued a joint statement Monday calling for all health care employers to require COVID-19 vaccinations for all their employees.

COVID-19 Vaccine Fails to Deliver SARS-CoV-2 Spike Antibody Responses in Multiple Myeloma

July 18th 2021

Suboptimal antibody responses to SARS-CoV-2 vaccination have been reported in patients with multiple myeloma, leaving them at a greater risk for developing severe COVID-19.

Patients With Urological Cancer and COVID-19 Undergoing Elective Surgery at Higher Risk for Mortality

July 10th 2021

Patients with a urological cancer who were also infected with COVID-19 and undergoing elective surgery for their disease, were found to have a significantly higher likelihood of experiencing respiratory complications and mortality than those without the virus.

Urologic Care Rates Decline Across US Demographics During Height of COVID-19 Pandemic

July 9th 2021

The provision of urologic care underwent a significant decline during the height of the COVID-19 pandemic across all demographic groups and practice settings in the United States, regardless of the timing of stay-at-home order mandates.

CTCA Leaders Provide Post-Pandemic Predictions in Oncology

July 8th 2021

Dr. Rariy, Ms. Brown, and Ms. Greenman discuss how the COVID-19 pandemic has led to a significant delay in cancer diagnoses, impacted the training of oncologists, and revolutionized telehealth.